S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:NUWE

Nuwellis (NUWE) Stock Price, News & Analysis

$0.36
-0.04 (-10.11%)
(As of 03/28/2024 ET)
Today's Range
$0.36
$0.41
50-Day Range
$0.36
$0.70
52-Week Range
$0.36
$5.73
Volume
420,269 shs
Average Volume
872,255 shs
Market Capitalization
$2.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Nuwellis MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
12.74% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.29mentions of Nuwellis in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.29) to ($1.22) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.22 out of 5 stars

NUWE stock logo

About Nuwellis Stock (NASDAQ:NUWE)

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama. Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

NUWE Stock Price History

NUWE Stock News Headlines

Maxim Group Keeps Their Buy Rating on Nuwellis (NUWE)
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.
Q4 2023 Nuwellis Inc Earnings Call
Earnings Preview For Nuwellis
Nuwellis Q4 Earnings Preview
Nuwellis earnings: here's what to expect
Nuwellis Inc NUWE
Nuwellis Stock (NASDAQ:NUWE), Short Interest Report
Nuwellis, Inc. (22SA.F)
See More Headlines
Receive NUWE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuwellis and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/05/2024
Today
3/28/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:NUWE
Fax
N/A
Employees
59
Year Founded
N/A

Profitability

Net Income
$-20,210,000.00
Net Margins
-227.99%
Pretax Margin
-227.90%

Debt

Sales & Book Value

Annual Sales
$8.86 million
Book Value
$0.53 per share

Miscellaneous

Free Float
6,741,000
Market Cap
$2.42 million
Optionable
Not Optionable
Beta
0.18
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Nestor Jaramillo Jr. (Age 67)
    President, CEO & Director
    Comp: $437.71k
  • Mr. Robert B. Scott (Age 44)
    Chief Financial Officer
    Comp: $252.6k
  • Mr. Neil P. Ayotte Esq. (Age 60)
    Senior VP, General Counsel, Secretary & Chief Compliance Officer
    Comp: $342.54k
  • Mr. John Kowalczyk
    Senior Vice President of Sales & Marketing
  • Ms. Sandra Eayrs
    Chief Human Resources Officer
  • Mr. Vitaliy Epshteyn (Age 46)
    Sr. Vice President of Operations & Engineering
  • Dr. John Lynn Jefferies FACC
    M.D., M.P.H., Chief Medical Officer & Member of Medical Advisory Board
  • Mr. Paul Wotta (Age 67)
    Corporate Controller

NUWE Stock Analysis - Frequently Asked Questions

Should I buy or sell Nuwellis stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nuwellis in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" NUWE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUWE, but not buy additional shares or sell existing shares.
View NUWE analyst ratings
or view top-rated stocks.

How have NUWE shares performed in 2024?

Nuwellis' stock was trading at $0.5809 on January 1st, 2024. Since then, NUWE shares have decreased by 38.8% and is now trading at $0.3556.
View the best growth stocks for 2024 here
.

Are investors shorting Nuwellis?

Nuwellis saw a increase in short interest in March. As of March 15th, there was short interest totaling 866,300 shares, an increase of 22.2% from the February 29th total of 708,700 shares. Based on an average daily trading volume, of 975,300 shares, the days-to-cover ratio is currently 0.9 days. Approximately 12.7% of the shares of the company are short sold.
View Nuwellis' Short Interest
.

When is Nuwellis' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our NUWE earnings forecast
.

How were Nuwellis' earnings last quarter?

Nuwellis, Inc. (NASDAQ:NUWE) posted its quarterly earnings data on Tuesday, March, 5th. The company reported ($2.24) earnings per share for the quarter, missing the consensus estimate of ($1.39) by $0.85. The firm had revenue of $2.55 million for the quarter. Nuwellis had a negative net margin of 227.99% and a negative trailing twelve-month return on equity of 218.79%. During the same quarter last year, the business posted ($5.00) EPS.

When did Nuwellis' stock split?

Nuwellis's stock reverse split on the morning of Sunday, December 11th 2022. The 1-100 reverse split was announced on Sunday, December 11th 2022. The number of shares owned by shareholders was adjusted after the market closes on Sunday, December 11th 2022. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Who are Nuwellis' major shareholders?

Nuwellis' stock is owned by a number of retail and institutional investors. Top institutional investors include Virtu Financial LLC (1.67%), Vanguard Group Inc. (1.53%) and Vanguard Group Inc. (1.53%).
View institutional ownership trends
.

How do I buy shares of Nuwellis?

Shares of NUWE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NUWE) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners